Valuation: Cegedim

Market Cap 144M 164M 133M 123M 233M 15.74B 238M 1.6B 622M 7.7B 617M 604M 26.74B P/E 2026 *
7.14x
P/E 2027 * 4.75x
Enterprise Value 322M 367M 298M 275M 521M 35.19B 532M 3.58B 1.39B 17.22B 1.38B 1.35B 59.78B EV / Sales 2026 *
0.49x
EV / Sales 2027 * 0.43x
Free-Float
36.52%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 83 24/10/2009
Director of Finance/CFO - 13/06/2016
Corporate Officer/Principal 55 25/11/2015
Director TitleAgeSince
Chairman 83 24/10/2009
Director/Board Member 70 13/06/2016
Director/Board Member 72 08/08/2010
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 164M
-0.78%-1.41%-40.09%+22.83% 408B
-4.13%-2.07%-47.77%+12.79% 192B
-2.66%+1.87%-47.32%-4.72% 114B
-2.09%+0.34%-43.92%+6.62% 42.53B
-3.58%+0.51%-76.35%+130.24% 34.23B
-2.63%+4.93%-25.66%+57.79% 30.15B
-3.51%-0.49%-34.38%+25.20% 17.16B
-2.48%-0.34%-33.94%-0.78% 12.53B
-0.96%+6.34%-41.08%+77.81% 11.41B
Average -2.41%+6.77%-43.39%+36.42% 95.79B
Weighted average by Cap. -2.21%+2.89%-43.69%+22.06%

Financials

2026 *2027 *
Net sales 660M 753M 610M 563M 1.07B 72.1B 1.09B 7.33B 2.85B 35.28B 2.83B 2.77B 122B 681M 777M 629M 581M 1.1B 74.36B 1.12B 7.56B 2.94B 36.39B 2.92B 2.85B 126B
Net income 21.25M 24.23M 19.62M 18.13M 34.36M 2.32B 35.05M 236M 91.64M 1.14B 90.98M 88.99M 3.94B 30.58M 34.87M 28.23M 26.09M 49.45M 3.34B 50.44M 339M 132M 1.63B 131M 128M 5.67B
Net Debt 178M 203M 164M 152M 288M 19.45B 294M 1.98B 768M 9.52B 763M 746M 33.04B 150M 171M 138M 128M 242M 16.35B 247M 1.66B 646M 8B 641M 627M 27.77B
Logo Cegedim
Cegedim is a European leading in collecting, processing, and distributing data and services related to medical information. Net sales break down by market as follows: - Insurance companies and services (73.4%): computerization of insurers and mutual benefit insurance companies, management of third-party payers and health care trends, external human resources management, computer and Internet services, etc. The group also develops processing sales statistics of pharmaceutical products, management of medical samples and promotional materials activities, etc. (GERS); - Health care professionals (20.6%): software for physicians and pharmacists, pharmaceutical data base, scientific, medical, and promotional information, etc.; - other (6%). France accounts for 91.9% of net sales.
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-